Zegona Communications plc (LON:ZEG)

Checkpoint Therapeutics Cash Flow Statement

Financials in millions EUR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	-351.04	-15.55	-3.31	79.91	13.97
Depreciation & Amortization	879.27	0.01	0.02	0.02	0
Stock-Based Compensation	72.23	0.09	0.04	-	-
Other Operating Activities	350.73	2.17	-0.02	-114.14	-20.52
Change in Accounts Receivable	-23.54	-0.4	-	-	-
Change in Inventory	-4.86	-	-	-	-
Change in Accounts Payable	214.33	9.74	-1.06	-	-
Change in Other Net Operating Assets	-	-	0.4	-4.93	-0.51
Operating Cash Flow	1,137	-3.93	-3.94	-39.14	-7.06
Capital Expenditures	-130.39	-	-	-0.03	-0.01
Cash Acquisitions	-290.05	-	-	-	-
Sale (Purchase) of Intangibles	-241.91	-	-	-	-
Investment in Securities	0.22	-	-	-	-
Other Investing Activities	-2,650	-289.76	0.03	439.55	10.15
Investing Cash Flow	-3,313	-289.76	0.03	439.51	10.14
Total Debt Issued	2,943	-	-	-	-
Long-Term Debt Repaid	-	-	-0.11	-11.03	-
Total Debt Repaid	-392.75	-	-0.11	-11.03	-
Net Debt Issued (Repaid)	2,550	-	-0.11	-11.03	-
Issuance of Common Stock	-	292.29	-	2.96	-
Repurchase of Common Stock	-	-	-	-388.53	-3.6
Common Dividends Paid	-	-	-	-12.17	-11.35
Other Financing Activities	-212.15	-	-	-	-
Financing Cash Flow	2,338	292.29	-0.11	-408.77	-14.95
Foreign Exchange Rate Adjustments	-	5.89	-0.64	3.71	0.08
Miscellaneous Cash Flow Adjustments	-	-	-0	-	-
Net Cash Flow	162.67	4.5	-4.67	-4.69	-11.79
Free Cash Flow	1,007	-3.93	-3.94	-39.18	-7.07
Free Cash Flow Margin	41.74%	-	-	-	-
Free Cash Flow Per Share	1.39	-0.04	-0.72	-0.23	-0.03
Cash Interest Paid	191.18	-	-	0.27	0.52
Levered Free Cash Flow	-	-1,175	-2.95	14.44	-7.28
Unlevered Free Cash Flow	-	-1,175	-2.95	14.67	-7.08
Change in Net Working Capital	-	1,172	0.93	-6.69	3.9

Updated Sep 27, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.